All News

Pairing two drugs that have shown to be effective in treating lymphoma might be the next step for mantle cell lymphoma treatment.

The possibility of carrying the BRCA gene mutation can be concerning to women who've been diagnosed with cancer especially when their children may eventually be affected.

Eating well is hard. Diet is personal.

We must remember what happened but also move forward.

Superior progression-free survival (PFS) was seen in patients with ovarian cancer who previously had a partial response (PR) to platinum-based therapy when they took Zejula (niraparib). This response was seen in patients with or without germline BRCA mutations, according to data from the ENGOT-OV16/NOVA trial presented at the 2017 ASCO Annual Meeting.

Progression-free survival (PFS) was not significantly improved with the combination of dalantercept plus Inlyta (axitinib) in patients with advanced renal cell carcinoma (RCC) compared with placebo, according to the results from the phase 2 DART trial.

A cancer survivor examines the link between health and humor.

The star heads into the world of ongoing breast cancer treatment just as a major new study of metastatic breast cancer in the United States gives a little more hope to those with the disease

After my cancer diagnosis, I realized that the only person to speak up for me was me. This is how I learned to speak up for myself and talk to those who represent me in Congress.

Imbruvica (ibrutinib) continues to demonstrate benefit in patients with chronic lymphocytic leukemia (CLL) who had at least one prior therapy, according to a four-year follow-up of the RESONATE study, which compared the BTK inhibitor to Arzerra (ofatumumab).

Changing the perception of what it means to be a survivor

When we are surviving cancer, when we want to see everybody else survive it too, another death is hard to take. When somebody passes, we are reminded of our own mortality—and distant losses—even as we mourn. Poetry helps.

How do we define how we feel and answer the question, "How do you feel?"

Tagrisso (osimertinib) had positive outcomes for patients with T790M-positive non–small cell lung cancer (NSCLC) for central nervous system (CNS) metastases.

Adding Perjeta (pertuzumab) to postoperative Herceptin (trastuzumab) improved survival in certain patients with breast cancer.

As any cancer survivor is aware, the blossom of hope can be a fragile flower.

Don’t let cancer keep you from your reaching your goals, ever.

Superfoods provide substances that shield our body from damage

Resources are available to help patients with cancer better manage nutrition.

Self-esteem and body image suffer after a breast cancer diagnosis. Finding a way to move past the trauma is challenging for some.

You’ve probably heard a lot of buzz about how healthy certain foods are good for you, but they're not the end all be all of a healthy diet.

There may be an upcoming shift in the treatment paradigm of patients with EGFR+ and ALK+ lung cancer.

My experience with hypnotherapy to curb the side effects of chemotherapy.

Fatigue is one of the most common complaints of patients.

Complementary therapies can make a difference in the cancer journey, and now we have to get oncologists to accept them

Combined modality treatment (CMT) could be considered a first course of treatment for patients with muscle-invasive bladder cancer, according to the authors of a recent study published in the International Journal of Radiation Oncology.

Patients with squamous cell carcinoma of the head and neck (SCCHC) and those with melanoma saw some promising activity with the drug combination of epacadostat and Opdivo (nivolumab), according to findings from the phase 1/2 ECHO-204 study presented at the 2017 ASCO Annual Meeting.

Little did I know, yoga would play a huge role in my life and recovery from breast cancer.